Citigroup Inc Fate Therapeutics Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Citigroup Inc holds 74,205 shares of FATE stock, worth $124,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,205

Previous 47,869 55.02%

Holding current value

$124,664

Previous $157,000 64.97%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.12 - $5.57 $82,168 - $146,691	26,336 Added 55.02%	74,205 $259,000
Q2 2024 Aug 12, 2024	SELL	$3.26 - $7.08 $1.88 Million - $4.07 Million	-575,189 Reduced 92.32%	47,869 $157,000
Q1 2024 May 10, 2024	SELL	$3.54 - $8.35 $782,000 - $1.84 Million	-220,904 Reduced 26.17%	623,058 $4.57 Million
Q4 2023 Feb 09, 2024	BUY	$1.65 - $3.94 $1.38 Million - $3.29 Million	835,245 Added 9581.79%	843,962 $3.16 Million
Q3 2023 Nov 09, 2023	SELL	$2.02 - $5.04 $2.16 Million - $5.38 Million	-1,066,932 Reduced 99.19%	8,717 $18,000
Q2 2023 Aug 10, 2023	SELL	$4.76 - $6.59 $234,472 - $324,616	-49,259 Reduced 4.38%	1,075,649 $5.12 Million
Q1 2023 May 11, 2023	BUY	$4.24 - $11.12 $3.94 Million - $10.3 Million	929,215 Added 474.83%	1,124,908 $6.41 Million
Q4 2022 Feb 09, 2023	SELL	$9.86 - $23.83 $327,381 - $791,227	-33,203 Reduced 14.51%	195,693 $1.97 Million
Q3 2022 Nov 10, 2022	BUY	$21.04 - $36.06 $541,275 - $927,679	25,726 Added 12.66%	228,896 $5.13 Million
Q2 2022 Aug 10, 2022	BUY	$17.78 - $42.39 $3 Million - $7.16 Million	168,833 Added 491.69%	203,170 $5.04 Million
Q1 2022 May 12, 2022	SELL	$29.67 - $60.28 $2.15 Million - $4.36 Million	-72,341 Reduced 67.81%	34,337 $1.33 Million
Q4 2021 Feb 10, 2022	SELL	$47.84 - $64.34 $3.01 Million - $4.04 Million	-62,844 Reduced 37.07%	106,678 $6.24 Million
Q3 2021 Nov 10, 2021	BUY	$59.27 - $95.73 $10 Million - $16.2 Million	169,522 New	169,522 $10 Million

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $163M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account